975 results on '"Musolino Caterina"'
Search Results
102. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study
103. Oxidative stress in oncohematologic diseases: an update
104. Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma
105. A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy
106. Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
107. Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
108. Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia
109. Use of Bisphosphonates in Hematology
110. Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma.
111. Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin
112. Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B
113. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience
114. Imatinib Mesylate Therapy Induces Reduction in Neutrophil Gelatinase-Associated Lipocalin Serum Levels and Increase in Leptin Concentrations in Chronic Myeloid Leukemia Patients in Molecular Remission
115. Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors
116. Chapter Five - Relationship between mitofusin 2 and cancer
117. Antiproliferative Effects of St. John’s Wort, Its Derivatives, and Other Hypericum Species in Hematologic Malignancies
118. Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
119. The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients
120. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
121. New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
122. Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
123. Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR–ABL-Negative Myeloproliferative Neoplasm
124. Immune checkpoint inhibitors in multiple myeloma: A review of the literature
125. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications
126. Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw
127. ABVD vs BEACOPP escalated in advanced‐stage Hodgkin’s lymphoma: Results from a multicenter European study
128. Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges
129. Anticancer Activity of Rosmarinus officinalis L.: Mechanisms of Action and Therapeutic Potentials
130. Oxidative Stress and Photodynamic Therapy of Skin Cancers: Mechanisms, Challenges and Promising Developments
131. Mitochondria-Targeted Antioxidant SkQ1 for Gammopathy-Related Corneal Damage
132. Interactions between the MicroRNAs and Microbiota in Cancer Development: Roles and Therapeutic Opportunities
133. Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology
134. Changes in Serum Interleukin-8 and sRAGE Levels in Multiple Myeloma Patients
135. Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role
136. Therapeutic potential of antagomiRs in haematological and oncological neoplasms
137. Cardiac Involvement in Patients With Hematologic Malignancies
138. Bisphosphonates Induce Apoptosis of Circulating Endothelial Cells in Multiple Myeloma Patients and in Subjects with Bisphosphonate-Induced Osteonecrosis of the Jaws
139. Epigenetic therapy in myelodysplastic syndromes
140. Serum levels of Interleukin-16 in a multiple myeloma patient with cutaneous involvement
141. Endothelial progenitor cells: pathogenetic role and therapeutic perspectives
142. JAK2V617F-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease
143. Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombo- cythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders
144. Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration
145. Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network
146. Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci
147. IMATINIB MESYLATE TREATMENT IN A PATIENT WITH CHEMORESISTANT Ph+ ACUTE MYELOID LEUKEMIA: POSSIBLE ROLE OF WILMSʼ TUMOR GENE 1
148. High-Dose Therapy and Autologous Peripheral Blood Stem Cells Transplantation Followed by a Very Low Reduced Intensity Regimen With Fludarabine + Cyclophosphamide and Allograft Improve Complete Remission Rate in De Novo Multiple Myeloma Patients
149. Immune thrombocytopenia: options and new perspectives.
150. Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.